Økonomisk analyse for sykehus og helsevesen
Kostnadsbesparelser
Systematisk og multimodal behandling
Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. (åpner nytt vindu)
Kilde: Ann Surg 2019;269(5):794-804.
Implementation of a patient blood management program based on a low-income country-adapted clinical decision support system. (åpner nytt vindu)
Kilde: Hematol Transfus Cell Ther 2022;44(3):374-8.
Methods of bloodless care, clinical outcomes, and costs for adult patients who decline allogeneic transfusions. (åpner nytt vindu)
Kilde: Anesth Analg. 2022;135(3):576-85.
Methods of bloodless care, clinical outcomes, and costs for adult patients who decline allogeneic transfusions. (åpner nytt vindu)
Kilde: Anesth Analg 2022;135(3):576-85.
Implementing a health system-wide patient blood management program with a clinical community approach. (åpner nytt vindu)
Kilde: Anesthesiology 2017;127(5):754-64.
Restrictive blood transfusion practices are associated with improved patient outcomes. (åpner nytt vindu)
Kilde: Transfusion 2014;54(10 Pt 2):2753-9.
Improving red cell transfusion in the elective surgical setting: an improvement collaborative with evaluation. (åpner nytt vindu)
Kilde: Vox Sang 2015;108(4):393-402.
Economic considerations on transfusion medicine and patient blood management. (åpner nytt vindu)
Kilde: Best Pract Res Clin Anaesthesiol 2013;27(1):59-68.
Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (åpner nytt vindu)
Kilde: Anaesthesia 2019;74(12):1534-41.
Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (åpner nytt vindu)
Kilde: Transfusion 2017;57(6):1347-58.
Health economics of patient blood management: a cost-benefit analysis based on a meta-analysis. (åpner nytt vindu)
Kilde: Vox Sang 2020;115(2):182-8.
Frequency and outcomes of blood products transfusion across procedures and clinical conditions warranting inpatient care: an analysis of the 2004 healthcare cost and utilization project nationwide inpatient sample database. (åpner nytt vindu)
Kilde: Am J Med Qual 2010;25(4):289-96.
ONTraC: A 20-year history of a successfully coordinated provincewide Patient Blood Management Program: lessons learned and goals achieved. (åpner nytt vindu)
Kilde: Anesth Analg 2022;135(3):448-58.
Effective reduction of blood product use in a community teaching hospital: when less is more. (åpner nytt vindu)
Kilde: Am J Med 2013;126(10):894-902.
Preoperativ behandling av anemi
Estimating the epidemiological and economic impact of implementing preoperative anaemia measures in the German healthcare system: the health economic footprint of patient blood management. (åpner nytt vindu)
Kilde: Adv Ther 2020;37(8):3515-36.
Clinical, economical and safety impact of ferric carboxymaltose use in Patient Blood Management programme in Portuguese National Health Service hospitals. (åpner nytt vindu)
Kilde: Sci Rep 2022;12(1):19335.
Associations between preoperative anaemia and hospital costs following major abdominal surgery: cohort study. (åpner nytt vindu)
Kilde: BJS Open 2021;5(2):zraa070.
Cost-effectiveness and budget impact of comprehensive anemia management, the first pillar of patient blood management, on the Turkish healthcare system. (åpner nytt vindu)
Kilde: Clinicoecon Outcomes Res 2022;14:415-26.
Perioperativ/intraoperativ blodsparing og blodgjenvinning
Clinical utility of autologous salvaged blood: a review. (åpner nytt vindu)
Kilde: J Gastrointest Surg 2020;24(2):464-72.
Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients. (åpner nytt vindu)
Kilde: Oncologist 2016;21(3):327-32.
Safety, cost savings, simplicity back broader use of bloodless surgery. (åpner nytt vindu)
Kilde: OR Manager 2013;29(5):1, 6, 8-9.
The volume of returned red blood cells in a large blood salvage program: where does it all go? (åpner nytt vindu)
Kilde: Transfusion 2011;51(10):2126-32.
An economic analysis of costs associated with development of a cell salvage program. (åpner nytt vindu)
Kilde: Anesth Analg 2007;104(4):869-75.
Begrens blodprøvetaking for å unngå iatrogen anemi
A model-based cost-effectiveness analysis of Patient Blood Management. (åpner nytt vindu)
Kilde: Blood Transfus 2019;17(1):16-26.
Evaluation of a multilevel laboratory stewardship intervention targeted to cardiac and thoracic surgical services at an academic medical center. (åpner nytt vindu)
Kilde: Arch Pathol Lab Med 2023;147(8):957-63.
A contemporary analysis of phlebotomy and iatrogenic anemia development throughout hospitalization in critically ill adults. (åpner nytt vindu)
Kilde: Anesth Analg 2022;135(3):501-10.